How often are the VBIO stock predictions updated?
"VBIO" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "VBIO" projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Vitality Biopharma Inc.
Is vitality BioPharma Inc (VBIO) stock a good investment?
According to our live Forecast System, Vitality Biopharma Inc stock is a bad long-term (1-year) investment*. "VBIO" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "VBIO" projections.
Why are short-term and long-term VBIO stock price predictions different?
Short-term and long-term VBIO (Vitality Biopharma Inc) stock price predictions may be different due to the different analyzed time series. Please read our Comment Policy before commenting.
What is Meridian Bioscience Inc’s investment rating?
MERIDIAN BIOSCIENCE INC has an Investment Rating of HOLD; a target price of $22.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium. VIVO: What does Argus have to say about VIVO?
Signals & Forecast
Support, Risk & Stop-loss
The Vitality Biophar stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is Vitality Biophar stock A Buy?
On the downside, the stock finds support just below today's level from accumulated volume at $0.30 and $0.30. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Vitality Biophar finds support just below today's level at $0.30.
Insiders are very positive as most new trades are buy in Vitality Biophar
Vitality Biophar holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Vitality Biophar
In the last 58 trades there were 20.02 million shares bought and 32.07 million shares sold. The last trade was done 176 days ago by Loconti Joseph E. who bough 1 thousand shares. For the period there is more stocks sold than bought, but the most of the latest transactions are buy.
Golden Star Signal
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
VBIO Target Price
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Vitality Biopharma Inc ( VBIO ) Stock Market info
VBIO price target in 14 days: 0.378 USD* upside and 0.295 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Who bought the breathtek business?
Recommendations: Buy or sell Vitality Biopharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vitality Biopharma share forecasts, stock quote and buy / sell signals below.
What is Meridian Bioscience?
Meridian Bioscience Inc (NASDAQ: VIVO) has agreed to acquire the North American BreathTek business from Otsuka America Pharmaceutical Inc for $20 million in cash. The transaction will close in Meridian's fiscal fourth quarter, which ends in September.
